Stocks360

ISR Immune System Regulation Holding AB (publ) (ISR.ST)

Stock analysis · STO · Healthcare · Biotechnology

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.44
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

ISR Immune System Regulation Holding AB (publ) (ISR.ST) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About ISR Immune System Regulation Holding AB (publ)

ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap